2,5-Dimethoxy-4-nitroamphetamine
This article relies largely or entirely upon a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. (April 2015) |
![]() |
|
Names | |
---|---|
Preferred IUPAC name
1-(2,5-Dimethoxy-4-nitrophenyl)propan-2-amine
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider |
|
PubChem CID
|
|
|
|
|
|
Properties | |
C11H16N2O4 | |
Molar mass | 240.26 g·mol−1 |
Melting point | 206 to 207 °C (403 to 405 °F; 479 to 480 K) (hydrochloride) 231-232 °C ((R)-isomer)[1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
2,5-Dimethoxy-4-nitroamphetamine (DON) is a recreational drug and amphetamine. It is a analog of DOM and DOB. It is also closely related to 2C-N.
Chemistry[edit]
DON is in a class of compounds commonly known as alpha-methyl phenethylamines, or amphetamines and the full chemical name is 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine. It has a stereocenter.
Effects[edit]
In his book PiHKAL (Phenethylamines I Have Known And Loved), Alexander Shulgin lists a dosage of DON as being 3-4.5 mg orally with amphetamine-like stimulation lasting 8–15 hours.[1]
Dangers[edit]
The toxicity of DON is not known.
Legality[edit]
DON is unscheduled in the United States, but because of its close similarity in structure and effects to DOM and DOB, possession and sale of DON may be subject to prosecution under the Federal Analog Act.[citation needed] DON is listed as a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act after the table of contents of Pihkal and Tihkal were added to the schedules.
See also[edit]
References[edit]
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Drugs from PiHKAL
|
|
---|---|
|
- Articles needing additional references from April 2015
- All articles needing additional references
- Chemical articles with multiple compound IDs
- Multiple chemicals in an infobox that need indexing
- Articles without KEGG source
- Articles without UNII source
- Articles with changed CASNo identifier
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from February 2013